These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29567862)

  • 1. Addressing the Problem of Multidrug-Resistant Organisms in Dialysis.
    D'Agata EMC
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):666-668. PubMed ID: 29567862
    [No Abstract]   [Full Text] [Related]  

  • 2. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA).
    Hebert C; Weber SG
    Infect Dis Clin North Am; 2011 Mar; 25(1):181-200. PubMed ID: 21316000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing an antimicrobial stewardship program in out-patient dialysis units.
    Cunha CB; D'Agata EM
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):551-555. PubMed ID: 27636769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly virulent pathogens--a post antibiotic era?
    Domin MA
    Br J Theatre Nurs; 1998 May; 8(2):14-8. PubMed ID: 9677888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities to Improve Antibiotic Prescribing in Outpatient Hemodialysis Facilities: A Report From the American Society of Nephrology and Centers for Disease Control and Prevention Antibiotic Stewardship White Paper Writing Group.
    Apata IW; Kabbani S; Neu AM; Kear TM; D'Agata EMC; Levenson DJ; Kliger AS; Hicks LA; Patel PR
    Am J Kidney Dis; 2021 May; 77(5):757-768. PubMed ID: 33045256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis.
    Pop-Vicas A; Strom J; Stanley K; D'Agata EM
    Clin J Am Soc Nephrol; 2008 May; 3(3):752-8. PubMed ID: 18322047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.
    D'Agata EMC; Tran D; Bautista J; Shemin D; Grima D
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1389-1397. PubMed ID: 30139804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC; Hageman JC
    Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial use and stewardship programs among dialysis centers.
    D'Agata EM
    Semin Dial; 2013; 26(4):457-64. PubMed ID: 23600755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis.
    Snyder GM; D'Agata EM
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):211-5. PubMed ID: 22240441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant organisms in dialysis patients.
    Calfee DP
    Semin Dial; 2013; 26(4):447-56. PubMed ID: 23627545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of health care associated infections and bacterial resistance : guidance for good practice].
    Foguena AK; Cometta A; Senn L
    Rev Med Suisse; 2016 Nov; 12(540):2026-2032. PubMed ID: 28696611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci].
    Hori S
    Nihon Rinsho; 2002 Nov; 60(11):2144-9. PubMed ID: 12440120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Stewardship and the Infection Control Practitioner: A Natural Alliance.
    Zhou S; Nagel JL; Kaye KS; LaPlante KL; Albin OR; Pogue JM
    Infect Dis Clin North Am; 2021 Sep; 35(3):771-787. PubMed ID: 34362543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit.
    Huskins WC
    Curr Opin Crit Care; 2007 Oct; 13(5):572-7. PubMed ID: 17762238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.